Pulmonx (LUNG) Revenue & Revenue Breakdown
Pulmonx Revenue Highlights
Latest Revenue (Y)
$83.79M
Latest Revenue (Q)
$22.54M
Main Geography (Y)
UNITED STATES
Pulmonx Revenue by Period
Pulmonx Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $83.79M | 22.01% |
| 2023-12-31 | $68.67M | 27.98% |
| 2022-12-31 | $53.66M | 10.84% |
| 2021-12-31 | $48.42M | 47.91% |
| 2020-12-31 | $32.73M | 0.42% |
| 2019-12-31 | $32.59M | 62.94% |
| 2018-12-31 | $20.00M | - |
Pulmonx generated $83.79M in revenue during NA 2024, up 22.01% compared to the previous quarter, and up 257.06% compared to the same period a year ago.
Pulmonx Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-03-31 | $22.54M | -5.16% |
| 2024-12-31 | $23.77M | 16.57% |
| 2024-09-30 | $20.39M | -1.91% |
| 2024-06-30 | $20.78M | 10.23% |
| 2024-03-31 | $18.85M | -2.20% |
| 2023-12-31 | $19.28M | 9.11% |
| 2023-09-30 | $17.67M | 2.76% |
| 2023-06-30 | $17.19M | 18.29% |
| 2023-03-31 | $14.54M | -5.77% |
| 2022-12-31 | $15.43M | 14.24% |
| 2022-09-30 | $13.50M | -3.21% |
| 2022-06-30 | $13.95M | 29.35% |
| 2022-03-31 | $10.79M | -21.32% |
| 2021-12-31 | $13.71M | 3.37% |
| 2021-09-30 | $13.26M | 8.67% |
| 2021-06-30 | $12.20M | 32.01% |
| 2021-03-31 | $9.24M | -5.96% |
| 2020-12-31 | $9.83M | -7.37% |
| 2020-09-30 | $10.61M | 188.92% |
| 2020-06-30 | $3.67M | -57.38% |
| 2020-03-31 | $8.62M | -16.71% |
| 2019-12-31 | $10.35M | 13.65% |
| 2019-09-30 | $9.10M | 23.59% |
| 2019-06-30 | $7.37M | 12.08% |
| 2019-03-31 | $6.57M | - |
Pulmonx generated $22.54M in revenue during Q1 2025, up -5.16% compared to the previous quarter, and up 116.91% compared to the same period a year ago.
Pulmonx Revenue Breakdown
Pulmonx Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 |
|---|---|---|---|---|---|
| Asia Pacific | $4.44M | $3.02M | $2.87M | $3.41M | $2.69M |
| EMEA | $22.33M | $19.34M | $18.15M | $19.88M | $13.81M |
| Other International Geographical Areas | $556.00K | $399.00K | $155.00K | $128.00K | $49.00K |
| UNITED STATES | $56.47M | $45.92M | $32.49M | $24.99M | $16.19M |
Pulmonx's latest annual revenue breakdown by geography, as of Dec 24: UNITED STATES (67.39%), EMEA (26.65%), Asia Pacific (5.30%), and Other International Geographical Areas (0.66%).
Quarterly Revenue by Country
| Country | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asia Pacific | $2.79M | $1.66M | $1.28M | $802.00K | $698.00K | $821.00K | $814.00K | $792.00K | $596.00K | $786.00K | $637.00K | $724.00K | $719.00K | $872.00K | $756.00K | $875.00K | $911.00K | $841.00K | $827.00K |
| Other International Geographical Areas | $38.00K | $101.00K | $145.00K | $139.00K | $171.00K | $96.00K | $164.00K | $68.00K | $71.00K | $57.00K | $58.00K | $40.00K | $79.00K | $37.00K | $12.00K | - | $10.00K | - | - |
| UNITED STATES | $14.22M | $15.88M | $13.84M | $13.88M | $12.87M | $13.72M | $11.84M | $11.02M | $9.34M | $9.46M | $8.40M | $8.62M | $6.01M | $7.28M | $6.86M | $6.57M | $4.29M | $4.87M | $5.34M |
| EMEA | $5.48M | $6.12M | $5.13M | $5.96M | $5.12M | $4.64M | $4.85M | $5.31M | $4.53M | $5.13M | $4.41M | $4.57M | $4.05M | $5.48M | $5.61M | $4.75M | $4.04M | $4.11M | $4.44M |
Pulmonx's latest quarterly revenue breakdown by geography, as of Mar 25: UNITED STATES (63.10%), EMEA (24.33%), Asia Pacific (12.40%), and Other International Geographical Areas (0.17%).
Pulmonx Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| ITGR | Integer | $1.72B | $437.39M |
| CNMD | CONMED | $1.31B | $321.26M |
| LIVN | LivaNova | $1.25B | $321.80M |
| INGN | Inogen | $335.70M | $80.08M |
| TMCI | Treace Medical Concepts | $209.36M | $68.71M |
| KIDS | OrthoPediatrics | $204.73M | $52.67M |
| AXGN | AxoGen | $187.34M | $49.41M |
| SIBN | SI-BONE | $167.18M | $49.00M |
| RXST | RxSight | $139.93M | $40.21M |
| SRDX | Surmodics | $126.08M | $28.09M |
| LUNG | Pulmonx | $83.79M | $22.54M |
| NPCE | NeuroPace | $79.91M | $21.47M |
| IRMD | IRadimed | $73.24M | $19.51M |
| APYX | Apyx Medical | $48.10M | $14.22M |
| OFIX | Orthofix Medical | - | $215.66M |